800-mg tablets, Each tablet contains 800 mg oxiracetam (4-hydroxy-2-oxo-1-pyrrolidinacetamide)
Cornstarch, sodium, magnesium stearate.
Neuromet is available in:
20 800-mg tablets, 10 1-g vials, 1 120-ml solution for oral
use, 10 5-ml single-dose flacons for oral use
Pharmaceutical classification (or type of
Mental syndromes caused by cerebral insufficiency, disturbances
in mental performance in the elderly.
INFORMATION WHICH SHOULD BE READ CAREFULLY BEFORE USING THIS MEDICINE
Known hypersensitivity on the part of the patient to the product.
Significant renal insufficiency.
In the case of renal insufficiency, the dosage of the product
should be lowered.
Expectant and nursing mothers:
This product should be used by pregnant women and nursing
mothers only when absolutely necessary and always under a doctors
Interactions with other medicines or interactions
of another nature:
No adverse interactions have been noted.
Neuromet does not affect in any way the patients capacity
to drive or to operate machinery.
KEEP OUT OF THE REACH OF CHILDREN
DIRECTIONS FOR USE:
Neuromets easy absorption enables the patient to adapt
easily to a single dose, depending on his symptoms and response
to treatment. Administration (oral or parenteral) may be chosen
according to the dosage to be taken, duration of treatment and
the patients overall condition.
The average dosage is 800 mg, twice daily.
800-mg tablets: one tablet, twice daily
Oral solution (120-ml flacon): 1 5-ml measure twice daily
Oral solution (5-ml single-dose flacon): 1 flacon twice daily.
During maintenance treatment, the daily dosage may be reduced
or increased, as the doctor deems necessary.
The daily dosage is 2 to 8 g depending on the patients
Administration is carried out by intravenous injection or infusion.
The 1-g vial can also be used for intramuscular injections.
Measures to take in case of overdose:
Symptoms arising from overdose of this product have not been
Although very rarely, increased psychomotor excitability and
sleep disorders have been observed, as a result of an extreme
reaction to the product by the patient. In such cases, it is recommended
simply to reduce the dosage.
Should you notice any adverse effect not described in this leaflet,
report it to your doctor or chemist.
The expiry date shown refers to the unopened product when
Do not use this medicine if the expiry date has passed.
Special precautions concerning storage:
No special storage precautions need to be taken for this pharmaceutical
to Anti-Aging Medicine Index
to Cognitive Science and Enhancement Index